特別損失計、外部収益 - ヘルス＆セーフティー、Liabilities Directly Associated With Assets Held For SaleIFRS他2件
- 【期間】
| 年度 | 特別損失計 | 外部収益 - ヘルス＆セーフティー | Liabilities Directly Associated With Assets Held For SaleIFRS | 研究開発費 - ケミカル関連事業 | 繰延税金負債（IFRS） |
|---|
| 2008/03 | 26.4億 | | - | | - | | - | | - | |
| 2009/03 | 60億 | +126.9% | - | | - | | - | | - | |
| 2010/03 | 29.7億 | -50.5% | - | | - | | - | | - | |
| 2011/03 | 88.6億 | +198% | - | | - | | - | | - | |
| 2012/03 | 42億 | -52.6% | - | | - | | - | | - | |
| 2013/03 | 84.2億 | +100.5% | - | | - | | - | | - | |
| 2014/03 | 35億 | -58.4% | - | | - | | - | | - | |
| 2015/03 | 78.5億 | +124.2% | - | | - | | - | | - | |
| 2016/03 | 50.3億 | -35.9% | - | | - | | - | | - | |
| 2017/03 | 64.9億 | +28.9% | - | | - | | - | | - | |
| 2018/03 | 67.5億 | +4% | - | | - | | - | | 89.6億 | |
| 2019/03 | 79.7億 | +18.1% | - | | - | | - | | 47.5億 | -47% |
| 2020/03 | 129億 | +61.7% | - | | - | | 7.26億 | | 92.5億 | +95% |
| 2021/03 | 10.2億 | -92.1% | - | | - | | 9.71億 | +33.7% | 82.2億 | -11.2% |
| 2022/03 | 33.1億 | +223.9% | 2175億 | | - | | 14.9億 | +53.8% | 127億 | +55.1% |
| 2023/03 | 14.8億 | -55.3% | 2360億 | +8.5% | - | | - | | 146億 | +14.6% |
| 2024/03 | - | | - | | - | | - | | 238億 | +63.3% |
